ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Optimized Cationic Lipid-assisted Nanoparticle for Delivering CpG Oligodeoxynucleotides to Treat Hepatitis B Virus Infection

Chen, Yi-Fang; Wang, Yan; Wang, Yue; Luo, Ying-Li; Lu, Zi-Dong; Du, Xiao-Jiao*; Xu, Cong-Fei*; Wang, Jun
Pharmaceutical Research2023-1DOI: 10.1007/s11095-022-03307-w
2被引8阅读
引用收藏
分享

摘要

Purpose Hepatitis B virus (HBV) infection is such a global health problem that hundreds of millions of people are HBV carriers. Current anti-viral agents can inhibit HBV replication, but can hardly eradicate HBV. Cytosine-phosphate-guanosine (CpG) oligodeoxynucleotides (ODNs) are an adjuvant that can activate plasmacytoid dendritic cells (pDCs) and conventional dendritic cells (cDCs) to induce therapeutic immunity for HBV eradication. However, efficient delivery of CpG ODNs into pDCs and cDCs remains a challenge. In this study, we constructed a series of cationic lipid-assisted nanoparticles (CLANs) using different cationic lipids to screen an optimal nanoparticle for delivering CpG ODNs into pDCs and cDCs. Methods We constructed different CLAN(CpG) using six cationic lipids and analyzed the cellular uptake of different CLAN(CpG) by pDCs and cDCs in vitro and in vivo, and further analyzed the efficiency of different CLAN(CpG) for activating pDCs and cDCs in both wild type mice and HBV-carrier mice. Results We found that CLAN fabricated with 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP) showed the highest efficiency for delivering CpG ODNs into pDCs and cDCs, resulting in strong therapeutic immunity in HBV-carrier mice. By using CLAN(CpG) as an immune adjuvant in combination with the injection of recombinant hepatitis B surface antigen (rHBsAg), HBV was successfully eradicated and the chronic liver inflammation in HBV-carrier mice was reduced. Conclusion We screened an optimized CLAN fabricated with DOTAP for efficient delivery of CpG ODNs to pDCs and cDCs, which can act as a therapeutic vaccine adjuvant for treating HBV infection.

学科与关键词

关键词
Polymeric nanoparticleCationic lipidCpG ODNsHBVVaccine
相关
加载中…
  • Emerging nanoparticle platforms for CpG oligonucleotide delivery
    Li, Mingqiang; Yao, Haochen; Yi, Ke; Lao, Yeh-Hsing; Shao, Dan; Tao, Yu*Biomaterials Science, 2024.
  • Programmable Delivery of Immune Adjuvant to Tumor-Infiltrating Dendritic Cells for Cancer Immunotherapy
    Liu, Jing; Li, Hong-Jun; Luo, Ying-Li; Chen, Yi-Fang; Fan, Ya-Nan; Du, Jin-Zhi; Wang, Jun*Nano Letters, 2020, 20(7): 4882-4889.被引 47
  • PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication
    Gao, Lixia; Yang, Jie; Feng, Jutao; Liu, Ziying; Dong, Ying; Luo, Jiangyan; Yu, Liangzhentian; Wang, Jiamei; Fan, Hongying; Ma, Weifeng*; Liu, Tiancai*Frontiers in Immunology, 2022, 13: 856463.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Pharmaceutical Research
发表日期
2023-01
卷期
第 40 卷, 第 1 期
页码
145-156
DOI
10.1007/s11095-022-03307-w
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82072048, 81901875, 32071378]; Guangdong Provincial Pearl River Talents Program [2017GC010713, 2017GC010482]; Science and Technology Program of Guangzhou, China [202103030004]; Guangdong Basic and Applied Basic Research Foundation [2022B1515020025, 2019A1515011878]; Fundamental Research Funds for the Central Universities

作者

  • C

    Chen, Yi-Fang (第一作者)

  • W

    Wang, Yan

查看全部 8 位作者收起作者
  • W

    Wang, Yue

  • L

    Luo, Ying-Li

  • L

    Lu, Zi-Dong

  • D

    Du, Xiao-Jiao (通讯)

  • X

    Xu, Cong-Fei (通讯)

  • W

    Wang, Jun

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417